Rui J. Lopes
Amsterdam, NH 1066CX, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
A First-in-Human Phase I Clinical Trial Evaluating Clinical Activity and Proof of Mechanism of Tobemstomig, a PD-1-LAG-3 Bispecific Antibody, in Patients with CPI-Experienced Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 21, 2025
The influence of amphiphilic quaternary ammonium palmitoyl glycol chitosan (GCPQ) polymer composition on oil-loaded nanocapsule architecture.
Journal: Journal of colloid and interface science
Published: May 23, 2024
Beyond the promise: evaluating and mitigating off-target effects in CRISPR gene editing for safer therapeutics.
Journal: Frontiers in bioengineering and biotechnology
Published: November 15, 2023
A Functional Survey of the Regulatory Landscape of Estrogen Receptor-Positive Breast Cancer Evolution.
Journal: Cancer discovery
Published: October 04, 2023
SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray.
Journal: Scientific reports
Published: December 16, 2020
PAX8 and MECOM are interaction partners driving ovarian cancer.
Journal: Nature communications
Published: July 27, 2020
A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis.
Journal: Genome biology
Published: June 02, 2020
A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferation.
Journal: Nucleic acids research
Published: January 29, 2019
PAX8 activates metabolic genes via enhancer elements in Renal Cell Carcinoma.
Journal: Nature communications
Published: October 12, 2018
CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells.
Journal: Cancer letters
Published: June 13, 2018
Last Updated: 09/26/2026